Drug Abuse Treatment Development and Research Mentoring

药物滥用治疗开发和研究指导

• 批准号: 7667756
• 负责人: Edward V. Nunes
• 金额: $ 17.48万
• 依托单位: COLUMBIA UNIVERSITY HEALTH SCIENCES
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7667756
• 关键词: Abstinence; Academy; Adolescent; Adult; Age; Aggressive behavior; Alcohol dependence; Alcohol or Other Drugs use; Alcohols; American; American Psychiatric Association; Anticonvulsants; Antidepressive Agents; Anxiety; Attention; Attention deficit hyperactivity disorder; Behavior Therapy; Behavioral; Biography; Biological; Biology; Biometry; Cannabis; Categories; Caucasians; Caucasoid Race; Cerebrum; Child; Childhood; Chronic; Clinical; Clinical Research; Clinical Trials Network; Cocaine; Cocaine Dependence; Cognitive; Cohort Studies; Collaborations; Combined Modality Therapy; Communities; Confidence Intervals; DSM-IV; DSM-V; Data; Data Set; Depression screen; Depressive Syndromes; Depressive disorder; Desipramine; Development; Diagnosis; Diagnostic; Diagnostic Procedure; Disease; Dorsal; Dropout; Drug Addiction; Drug abuse; Drug usage; Early identification; Early treatment; Educational process of instructing; Effectiveness; Emotional; Evaluation; Faculty; Family; Feeling suicidal; Fellowship; Fellowship Program; First Degree Relative; Fluoxetine; Follow-Up Studies; Fostering; Free Will; Functional disorder; Funding; Future; Glucose; Goals; Guidelines; HIV; Heterogeneity; Image; Imipramine; Impairment; Inpatients; Intervention; Interview; Journals; K-Series Research Career Programs; Leadership; Link; Long Island; Maintenance; Major Depressive Disorder; Manuals; Marijuana Dependence; Measures; Memory; Mental disorders; Mentors; Mentorship; Meta-Analysis; Metabolic; Metabolism; Methadone; Methods; Modeling; Modification; Mood Disorders; Moods; Morbidity - disease rate; Naltrexone; National Institute of Drug Abuse; National Institute on Alcohol Abuse and Alcoholism; Negative Reinforcements; Neurologic; Opiate Addiction; Opioid; Outcome; Outpatients; Pain; Parent-Child Relations; Parents; Pathological Gambling; Patient Self-Report; Patients; Pattern; Pharmaceutical Preparations; Pharmacological Treatment; Placebo Control; Placebo Effect; Population; Positron-Emission Tomography; Post-Traumatic Stress Disorders; Postdoctoral Fellow; Preventive Intervention; Process; Psychiatric Diagnosis; Psychiatry; Psychopathology; Publications; Published Comment; Recommendation; Recording of previous events; Research; Research Personnel; Resources; Rest; Risk; Risk Factors; Risk Reduction; Sampling; Scanning; Schizophrenia; School-Age Population; Schools; Scientist; Screening procedure; Self Medication; Series; Serotonin; Sertraline; Source; Structure; Subgroup; Substance Addiction; Substance abuse problem; Substance-Related Disorders; Symptoms; Syndrome; System; TNFRSF5 gene; Testing; Time; Toxic effect; Trauma; Tricyclic Antidepressive Agents; Vertical Disease Transmission; Withdrawal; Woman; Work; addiction; alcohol seeking behavior; base; career; cingulate cortex; clinically significant; community based treatment; depressed; depression; depressive symptoms; design; disorder later incidence prevention; early onset; effective therapy; effectiveness trial; high risk; improved; interest; mental disorder diagnosis; multi-site trial; nefazodone; neuropsychological; next generation; novel; outcome forecast; patient oriented research; placebo controlled study; prognostic; programs; psychosocial; skills; symposium; theories; therapy development; treatment planning; treatment program; valproate

DESCRIPTION (provided by applicant): The goal of this K24 Mid-Career Clinician-Scientist proposal is to allow the Candidate, Dr. Edward Nunes, to continue to expand his program of research and research mentorship in the field of drug abuse treatment development. The Candidate's research program focuses on two related themes, the treatment of co-occurring psychopathology in substance dependent patients, and the development of combinations of behavioral and pharmacological treatments for drug dependence. Major activities and accomplishments have included a series of studies examining the efficacy of antidepressant medications for treatment of opioid, cocaine, and alcohol dependent patients with depression, projects applying advances in behavioral therapies to naltrexone maintenance for opioid dependence and to treatment of depression among methadone maintained patients, applications of behavioral therapy to enhance the design of cocaine medications development trials, and multi-site effectiveness trials in the NIDA Clinical Trials Network. Through collaborations and the work of colleagues Dr. Nunes has, and continues to mentor, his agenda has expanded to examine structured psychiatric diagnostic methods, HIV risk reduction, and other co-occurring psychopathology including attention deficit hyperactivity disorder, impulsive aggression, post-traumatic stress disorder, pathological gambling, neuropsychological functioning, and childhood psychopathology and risk for drug dependence. Over the course of the proposed K24 Dr. Nunes will serve as Principle Investigator on a Center Project, two R01s, and the Long Island Node of the Clinical Trials Network, and as Co-l, Sponsor, or Co-Sponsor on funded projects of junior colleagues and mentored K awards. In particular the K24 will free Dr. Nunes' time and provide resources to pursue the development of new initiatives and collaborations in treatment research and to create opportunities in patient-oriented research for junior colleagues. The mentoring plan will serve young investigators at three main levels, 1) junior faculty with early or emerging independent research programs many of whom Dr. Nunes has mentored since fellowship or during K awards, 2) three current K23 awardees for whom Dr. Nunes serves as Sponsor, and three current (or anticipated) K23 or K01 awardees for whom he serves as Co-Sponsor or Consultant, and 3) Post doctoral fellows in clinical research in the Department's NIDA funded T32 research fellowship program. In addition Dr. Nunes will seek to foster independent research initiatives and collaborations involving the clinical leadership of community-based treatment programs participating in the Clinical Trials Network. The ultimate goals are to improve the treatment of drug dependent patients through clinical research and to help foster the next generation of clinician-researchers.

描述（由申请人提供）：这个K24中期职业临床医生-科学家提案的目标是允许候选人爱德华·努涅斯博士继续扩大他在药物滥用治疗发展领域的研究和研究指导计划。候选人的研究项目主要集中在两个相关的主题，药物依赖患者的同时发生的精神病理的治疗，以及药物依赖的行为和药物治疗组合的发展。主要活动和成就包括一系列研究，检查抗抑郁药物治疗阿片类药物、可卡因和酒精依赖抑郁症患者的疗效，将行为疗法的进展应用于维持阿片类药物依赖的纳曲酮和美沙酮维持患者的抑郁症治疗的项目，应用行为疗法加强设计可卡因药物开发试验，以及NIDA临床试验网络的多站点有效性试验。通过与同事的合作和工作，Nunes博士已经并将继续指导，他的议程已经扩展到检查结构化精神诊断方法，降低艾滋病毒风险，以及其他共同发生的精神病理学，包括注意缺陷多动障碍，冲动攻击，创伤后应激障碍，病理性赌博，神经心理功能，儿童精神病理学和药物依赖风险。在拟议的K24过程中，Nunes博士将担任中心项目，两个r01和临床试验网络长岛节点的首席研究员，并担任初级同事和指导K奖资助项目的co - 1，赞助商或共同赞助商。特别是K24将解放Nunes博士的时间，并提供资源，以追求治疗研究的新举措和合作的发展，并为初级同事创造以患者为导向的研究机会。该指导计划将为三个主要层次的年轻研究人员提供服务：1)拥有早期或新兴独立研究项目的初级教师，其中许多人自奖学金或K奖期间就得到了Nunes博士的指导；2)目前有三名K23奖获得者，Nunes博士担任其赞助人；3)该系NIDA资助的T32研究奖学金项目临床研究博士后。此外，Nunes博士将寻求促进独立的研究倡议和合作，包括参与临床试验网络的社区治疗项目的临床领导。最终目标是通过临床研究改善药物依赖患者的治疗，并帮助培养下一代临床研究人员。